Is Crinetics Pharmaceuticals Inc’s (NASDAQ: CRNX) -1.98% Loss This Week Telling Us Something New?
During the last session, Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)’s traded shares were 0.56 million, with the beta value of the company hitting 0.64. At the end